Chromosomal copy number heterogeneity predicts survival rates across cancers

Intratumour heterogeneity (ITH) is associated with worse prognosis in cancer, and efficient frameworks to measure it are needed. Here the authors develop a method to estimate copy number heterogeneity, and propose that it is driven by chromosomal instability and can predict pan-cancer survival.

Guardado en:
Detalles Bibliográficos
Autores principales: Erik van Dijk, Tom van den Bosch, Kristiaan J. Lenos, Khalid El Makrini, Lisanne E. Nijman, Hendrik F. B. van Essen, Nico Lansu, Michiel Boekhout, Joris H. Hageman, Rebecca C. Fitzgerald, Cornelis J. A. Punt, Jurriaan B. Tuynman, Hugo J. G. Snippert, Geert J. P. L. Kops, Jan Paul Medema, Bauke Ylstra, Louis Vermeulen, Daniël M. Miedema
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/264d1331d97845559b189b69b84d9dcb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:264d1331d97845559b189b69b84d9dcb
record_format dspace
spelling oai:doaj.org-article:264d1331d97845559b189b69b84d9dcb2021-12-02T15:49:44ZChromosomal copy number heterogeneity predicts survival rates across cancers10.1038/s41467-021-23384-62041-1723https://doaj.org/article/264d1331d97845559b189b69b84d9dcb2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23384-6https://doaj.org/toc/2041-1723Intratumour heterogeneity (ITH) is associated with worse prognosis in cancer, and efficient frameworks to measure it are needed. Here the authors develop a method to estimate copy number heterogeneity, and propose that it is driven by chromosomal instability and can predict pan-cancer survival.Erik van DijkTom van den BoschKristiaan J. LenosKhalid El MakriniLisanne E. NijmanHendrik F. B. van EssenNico LansuMichiel BoekhoutJoris H. HagemanRebecca C. FitzgeraldCornelis J. A. PuntJurriaan B. TuynmanHugo J. G. SnippertGeert J. P. L. KopsJan Paul MedemaBauke YlstraLouis VermeulenDaniël M. MiedemaNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Erik van Dijk
Tom van den Bosch
Kristiaan J. Lenos
Khalid El Makrini
Lisanne E. Nijman
Hendrik F. B. van Essen
Nico Lansu
Michiel Boekhout
Joris H. Hageman
Rebecca C. Fitzgerald
Cornelis J. A. Punt
Jurriaan B. Tuynman
Hugo J. G. Snippert
Geert J. P. L. Kops
Jan Paul Medema
Bauke Ylstra
Louis Vermeulen
Daniël M. Miedema
Chromosomal copy number heterogeneity predicts survival rates across cancers
description Intratumour heterogeneity (ITH) is associated with worse prognosis in cancer, and efficient frameworks to measure it are needed. Here the authors develop a method to estimate copy number heterogeneity, and propose that it is driven by chromosomal instability and can predict pan-cancer survival.
format article
author Erik van Dijk
Tom van den Bosch
Kristiaan J. Lenos
Khalid El Makrini
Lisanne E. Nijman
Hendrik F. B. van Essen
Nico Lansu
Michiel Boekhout
Joris H. Hageman
Rebecca C. Fitzgerald
Cornelis J. A. Punt
Jurriaan B. Tuynman
Hugo J. G. Snippert
Geert J. P. L. Kops
Jan Paul Medema
Bauke Ylstra
Louis Vermeulen
Daniël M. Miedema
author_facet Erik van Dijk
Tom van den Bosch
Kristiaan J. Lenos
Khalid El Makrini
Lisanne E. Nijman
Hendrik F. B. van Essen
Nico Lansu
Michiel Boekhout
Joris H. Hageman
Rebecca C. Fitzgerald
Cornelis J. A. Punt
Jurriaan B. Tuynman
Hugo J. G. Snippert
Geert J. P. L. Kops
Jan Paul Medema
Bauke Ylstra
Louis Vermeulen
Daniël M. Miedema
author_sort Erik van Dijk
title Chromosomal copy number heterogeneity predicts survival rates across cancers
title_short Chromosomal copy number heterogeneity predicts survival rates across cancers
title_full Chromosomal copy number heterogeneity predicts survival rates across cancers
title_fullStr Chromosomal copy number heterogeneity predicts survival rates across cancers
title_full_unstemmed Chromosomal copy number heterogeneity predicts survival rates across cancers
title_sort chromosomal copy number heterogeneity predicts survival rates across cancers
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/264d1331d97845559b189b69b84d9dcb
work_keys_str_mv AT erikvandijk chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT tomvandenbosch chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT kristiaanjlenos chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT khalidelmakrini chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT lisanneenijman chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT hendrikfbvanessen chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT nicolansu chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT michielboekhout chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT jorishhageman chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT rebeccacfitzgerald chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT cornelisjapunt chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT jurriaanbtuynman chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT hugojgsnippert chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT geertjplkops chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT janpaulmedema chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT baukeylstra chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT louisvermeulen chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
AT danielmmiedema chromosomalcopynumberheterogeneitypredictssurvivalratesacrosscancers
_version_ 1718385679609626624